Good to know

  1. 10 important facts to know about the new migraine injection

    You might have heard about a new medicine that’s just been approved to treat migraine. Here’s what you need to know.

    Glasses

    Read more »
  2. What is Tudca?

    News update5 common questions about the supplement that may be useful for ALS, Parkinson's and Alzheimers.

    Read more »
  3. What is ‘cold chain’ delivery?

    Find out about what it means to order and receive temperature-controlled medicines.

    Map

    Read more »
  4. How does Alecensa (alectinib) work for ALK+ NSCLC?

    Line up of people (stock)An easy to understand guide on how alectinib works.

    Read more »
  5. What’s after platinum-based chemo? Niraparib as a maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancer

    Dandelion (conceptual)A closer look at the function and efficicacy of niraparib as a maintenace treatment.

    Read more »
  6. News for metastatic melanoma patients

    There are a number of medicines available for melanoma patients. In this article we examine one newer medicine and discuss it's efficacy and use. 

    Elderly couple cooking together 

    Read more »
  7. Why is niraparib (Zejula) important for women with recurrent ovarian cancer?

    The European Medicines Agency has recently approved Niraparib (Zejula) for use in the European Union as a treatment for women struggling with a specific type of advanced ovarian cancer known as high-grade serous epithelial ovarian cancer, which includes cancers that affect the peritoneum and/or the fallopian tubes.

    smiling woman with friends 

    Read more »
  8. What’s the difference between a brand name and a generic medicine?

    brand name generic medicine
    When a new medicine gets approved for use and for sale in a specific region, it’s usually given a brand name by the pharmaceutical company who discovered or developed it.

    Read more »
  9. 10 Things You Need to Know About Lung Cancer

    In 2015, an estimated 221,200 people in the U.S. will be diagnosed with lung cancer, which is 13 percent of all cancer diagnoses.

    lung cancer knowledge

    Read more »
  10. Why is there often a substantial delay in getting access to new medicines – even after they are approved?

    We talk to Sera, our Medicines Sourcing Manager about why drug delays happen...

    Drug delays

    Read more »
  11. The Parcel of Success

    Why every little package is a big deal

    Parcel of Succes

    Read more »
  12. What is alectinib (Alecensa) and why is the latest news a positive step for lung cancer patients?

    How effective is alectinib (Alecensa)? The latest news and updates

    alecensa lung cancer

    Read more »